AG0003CJ

1009820-21-6 | 5-[(3-Chlorophenyl)amino]benzo[c]2,6-naphthyridine-8-carboxylic acid

AG0003CJ

SDS

COA

TIP This product is typically in stock.Please contact us for quotation.

Request For Quotation

• mg
• g
• kg
• ml
• L

No data

• mg
• g
• kg
• ml
• L

No data

No data

Inquire

CAS Number	1009820-21-6
Catalog Number	AG0003CJ(AGN-PC-04QK78)
Chemical Name	5-[(3-Chlorophenyl)amino]benzo[c]2,6-naphthyridine-8-carboxylic acid
IUPAC Name	5-(3-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid
InChI	InChI=1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25)
InChI Key	MUOKSQABCJCOPU-UHFFFAOYSA-N
MDL Number	MFCD13184796
Molecular Formula	C19H12ClN3O2
Molecular Weight	349.7705
SMILES	O=C(C1=CC=C2C(N=C(NC3=CC=CC(Cl)=C3)C4=C2C=NC=C4)=C1)O
UNII	C6RWP0N0L2
Synonyms	5-(3-chlorophenylamino)benzo(c)(2,6)naphthyridine-8-carboxylic acid, CX 4945, CX-4945, CX4945, 1009820-21-6, Silmitasertib, CX-4945, 5-((3-Chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid, CX-4945 (Silmitasertib), CX4945, CX 4945, UNII-C6RWP0N0L2, 5-[(3-chlorophenyl)amino]-Benzo[c]-2,6-naphthyridine-8-carboxylic acid, 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid, C6RWP0N0L2, Silmitasertib (CX-4945), CHEMBL1230165, AK-82006, 5-((3-Chlorophenyl)amino)benzo-[c][2,6]naphthyridine-8-carboxylic acid, 5-[(3-Chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-Carboxylic Acid, C19H12ClN3O2, W-204393, 5-[(3-chlorophenyl)amino]benzo[c]2,6-naphthyridine-8-carboxylic acid, Silmitasertib [INN], 3NG, PubChem22588, cx-4945-silmitasertib, Silmitasertib; CX 4945, CX-4945 (Silmitaserib), CX 4945 (Silmitasertib), CX-4945 - Silmitasertib, SCHEMBL629082, GTPL8126, CTK8B6574, KS-00000PRB, AOB2757, DTXSID40143602, EX-A070, QCR-248, SYN1109, HMS3244M13, HMS3244M14, HMS3244N13, HMS3655F16, 5-(3-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid, BCP02399, ABP000327, ANW-53685, BDBM50335638, MFCD13184796, RS0028, s2248, ZINC58638454, AKOS005266722, ACN-029586, AN-1295, BCP9000560, CS-0563, CX-4945/CX4945, EX-8673, MP-1904, SB17201, NCGC00263192-01, NCGC00263192-02, 4CA-1158, AC-28426, AS-16253, BC638769, HY-50855, AB0033729, AJ-113170, AX8226527, DB-016103, TC-142430, FT-0723994, ST24023701, SW218157-2, X7439, A25034, J-000296, J-516169, CX-4945,CAS:1009820-21-6, CX 4945,CX4945, 1009820-21-6, 5-[(3-chlorophenyl)amino]pyrido[4,3-c]quinoline-8-carboxylic acid, 5-[(3-Chlorophenyl)amino]benzo[c]-2,6-naphthyridine-8-carboxylic acid, Benzo[c]-2,6-naphthyridine-8-carboxylic acid, 5-[(3-chlorophenyl)amino]-, CX-4945|||5-(3-Chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid, CX-4945 Silmitasertib, D09JEJ, cc-639, UNII-N1E607PU86, RW4112, A8330, A11060, C555142, 5-(3-chlorophenylamino)benzo(c)(2,6)naphthyridine-8-carboxylic acid, Silmitasertib, 98%, a potent and selective ATP-competitive CK2 inhibitor - 25MG 25mg,

Complexity	491
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	349.062g/mol
Formal Charge	0
Heavy Atom Count	25
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	349.774g/mol
Monoisotopic Mass	349.062g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	75.1A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	4.4

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H332-H335
Packing Group
Precautionary statements	P261-P280-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number